Kategori: JCN Newswire

Toyota City, Japan, Aug 22, 2024 – (JCN Newswire via SeaPRwire.com) – TOYOTA GAZOO Racing (TGR) began accepting orders today for the new GR Supra GT4 EVO2, for which vast feedback from racing teams and drivers around the world was leveraged to achieve higher levels of performance, reliability, and operability. Since the launch of the…

TOKYO, Aug 22, 2024 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Heavy Industries, Ltd. (MHI), together with Kirin Group companies Kirin Beverage Co., Ltd. and Kirin Group Logistics Co., Ltd., in August will begin a joint demonstration aimed at establishing elemental technologies for the automation of inbound and outbound processes at beverage warehouses, and the…

TOKYO, Aug 22, 2024 – (JCN Newswire via SeaPRwire.com) – Techstars Tokyo Accelerator powered by JETRO and Mitsui Fudosan is proud to announce the 12 startups selected for the Class of 2024. These promising, early-stage companies are addressing challenges in categories such as Women’s Health, Gaming, Animation, Productivity Enhancement, B2B Business Intelligence, Robotics and more….

TOKYO, Aug 21, 2024 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that Team Mitsubishi Ralliart, for which the company provides technical support, has won fifth place overall in the Asia Cross Country Rally (hereafter, AXCR) 2024, held in Thailand from August 11 to 17, with the Triton1 (T1 specification,…

KYOTO, JAPAN, Aug 14, 2024 – (JCN Newswire via SeaPRwire.com) – Valuufy, a pioneering fintech startup drawn from a decades’ work in measuring and creating sustainable value at Doshisha University’s Value Research Center, has launched with its groundbreaking ValuuCompass, a comprehensive framework set to transform sustainable business practices and sustainability investing by providing a fully…

TOKYO and CAMBRIDGE, Mass., Aug 14, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQEMBI®” (lecanemab) for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI…